{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0078-1007",
      "generic_name": "ofatumumab",
      "labeler_name": "Novartis Pharmaceuticals Corporation",
      "brand_name": "KESIMPTA",
      "active_ingredients": [
        {
          "name": "OFATUMUMAB",
          "strength": "20 mg/.4mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0078-1007-68",
          "description": "1 SYRINGE, GLASS in 1 CARTON (0078-1007-68)  / .4 mL in 1 SYRINGE, GLASS",
          "marketing_start_date": "20200820",
          "sample": false
        },
        {
          "package_ndc": "0078-1007-98",
          "description": "1 SYRINGE, GLASS in 1 CARTON (0078-1007-98)  / .4 mL in 1 SYRINGE, GLASS",
          "marketing_start_date": "20200820",
          "sample": true
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Novartis Pharmaceuticals Corporation"
        ],
        "rxcui": [
          "2390949",
          "2390954"
        ],
        "spl_set_id": [
          "6a8a3f53-2062-48ff-9dbe-b939df133ca3"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175657",
          "N0000175078"
        ],
        "pharm_class_epc": [
          "CD20-directed Cytolytic Antibody [EPC]"
        ],
        "pharm_class_moa": [
          "CD20-directed Antibody Interactions [MoA]"
        ],
        "unii": [
          "M95KG522R0"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "ab75831e-d802-456a-bae6-7c85ef8dc3ed",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20091026",
      "product_id": "0078-1007_ab75831e-d802-456a-bae6-7c85ef8dc3ed",
      "application_number": "BLA125326",
      "brand_name_base": "KESIMPTA",
      "pharm_class": [
        "CD20-directed Antibody Interactions [MoA]",
        "CD20-directed Cytolytic Antibody [EPC]"
      ]
    }
  ]
}